Advertisement

Topics

Gene variants in AMD may predict 3-year outcomes with PDT

18:00 EDT 1 Aug 2017 | Healio

Variants of the ARMS2 gene may be associated with the results of photodynamic therapy in wet age-related macular degeneration, according to a study.The 65 patients included in the study were recruited from the ophthalmology department at Kobe University Hospital in Japan. All patients had previously taken part in a study evaluating the 12-month outcomes of PDT in wet AMD between 2005 and 2008. As the authors noted, anti-VEGF agents were not available in Japan at the time and PDT was commonly used to treat AMD. In addition, PDT is still considered a beneficial therapy in patients with polypoidal choroidal vasculopathy, which is frequently diagnosed in Japan.

Original Article: Gene variants in AMD may predict 3-year outcomes with PDT

NEXT ARTICLE

More From BioPortfolio on "Gene variants in AMD may predict 3-year outcomes with PDT"

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...